1. Home
  2. LUNG vs NOTE Comparison

LUNG vs NOTE Comparison

Compare LUNG & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • NOTE
  • Stock Information
  • Founded
  • LUNG 1995
  • NOTE 2013
  • Country
  • LUNG United States
  • NOTE United States
  • Employees
  • LUNG N/A
  • NOTE N/A
  • Industry
  • LUNG Industrial Specialties
  • NOTE EDP Services
  • Sector
  • LUNG Health Care
  • NOTE Technology
  • Exchange
  • LUNG Nasdaq
  • NOTE Nasdaq
  • Market Cap
  • LUNG 124.0M
  • NOTE 83.1M
  • IPO Year
  • LUNG 2020
  • NOTE N/A
  • Fundamental
  • Price
  • LUNG $2.87
  • NOTE $0.69
  • Analyst Decision
  • LUNG Buy
  • NOTE Strong Buy
  • Analyst Count
  • LUNG 6
  • NOTE 6
  • Target Price
  • LUNG $11.53
  • NOTE $2.63
  • AVG Volume (30 Days)
  • LUNG 317.8K
  • NOTE 3.4M
  • Earning Date
  • LUNG 07-30-2025
  • NOTE 08-07-2025
  • Dividend Yield
  • LUNG N/A
  • NOTE N/A
  • EPS Growth
  • LUNG N/A
  • NOTE N/A
  • EPS
  • LUNG N/A
  • NOTE N/A
  • Revenue
  • LUNG $87,473,000.00
  • NOTE $115,665,000.00
  • Revenue This Year
  • LUNG $18.02
  • NOTE N/A
  • Revenue Next Year
  • LUNG $18.17
  • NOTE $41.14
  • P/E Ratio
  • LUNG N/A
  • NOTE N/A
  • Revenue Growth
  • LUNG 19.84
  • NOTE N/A
  • 52 Week Low
  • LUNG $2.50
  • NOTE $0.48
  • 52 Week High
  • LUNG $9.37
  • NOTE $2.07
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 39.07
  • NOTE 61.52
  • Support Level
  • LUNG $2.62
  • NOTE $0.66
  • Resistance Level
  • LUNG $2.88
  • NOTE $0.84
  • Average True Range (ATR)
  • LUNG 0.17
  • NOTE 0.07
  • MACD
  • LUNG 0.05
  • NOTE 0.03
  • Stochastic Oscillator
  • LUNG 39.68
  • NOTE 68.32

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About NOTE FiscalNote Holdings Inc.

FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.

Share on Social Networks: